Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Rankning i aktier #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Aktiekurs
$0.12164306
Senast synkroniserad: 2024-11-11
Marknadsvärde
$38.53M
Förändring (1 dag)
-4.14%
Förändring (1 år)
0.00%
Land
AU
Handel PharmAust Limited (PAA)

Kategori

Aktiekurshistorik för PharmAust Limited (PAA)
Högsta slutkurs: $0.12 den 2024-11-01

Lägsta slutkurs: $3.11 den 2001-10-01
Aktiekurshistorik för PharmAust Limited från 2001 till 2026
Årlig aktiekursutveckling
År Prestanda
2024 72.79%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$542.77 37.63%
US
$1.03K 55.84%
NL
$120.74 -14.98%
AU
$145.16 439.84%
US
$756.15 6.24%
CH